Choosing Wisely® aims to promote conversations between providers and patients by helping patients choose care that is:
- Supported by evidence
- Not duplicative of other tests or procedures already received
- Free from harm
- Truly necessary
I thought I would try to give this a trial run by comparing the recommendations of 'Choose Wisely' and 'Choose Wisely Canada' for Prostate Cancer.
" Don’t routinely screen for prostate cancer using a prostate-specific antigen (PSA) test or digital rectal exam."
There is convincing evidence that PSA-based screening
leads to substantial over-diagnosis of prostate tumors. Many tumors
will not harm patients, while the risks of treatment are significant.
Physicians should not offer or order PSA screening unless they are prepared to engage in shared decision making that enables an informed choice by patients."
How This List Was Created : The American Academy of Family Physicians (AAFP) has identified this list of clinical recommendations for the second phase of the Choosing Wisely campaign. The goal was to identify items common in the practice of family medicine supported by a review of the evidence that would lead to significant health benefits, reduce risks, harms and costs. For each item, evidence was reviewed from appropriate sources such as evidence reviews from the Cochrane Collaboration, and the Agency for Healthcare Research and Quality. The AAFP’s Commission on Health of the Public and Science and Chair of the Board of Directors reviewed and approved the recommendations.
When I tried to see if the Canadian site made the same recommendation extensive searching showed no mention of prostate disease of any sort. Further searching indicated that the Canadian Urological Society report is pending.
Incidentally, I did not see any mention of the time involvement of the 'conversations' and of it's impact on the patient load of the physician and how this can best be accomplished.
How This List Was Created : The American Academy of Family Physicians (AAFP) has identified this list of clinical recommendations for the second phase of the Choosing Wisely campaign. The goal was to identify items common in the practice of family medicine supported by a review of the evidence that would lead to significant health benefits, reduce risks, harms and costs. For each item, evidence was reviewed from appropriate sources such as evidence reviews from the Cochrane Collaboration, and the Agency for Healthcare Research and Quality. The AAFP’s Commission on Health of the Public and Science and Chair of the Board of Directors reviewed and approved the recommendations.
When I tried to see if the Canadian site made the same recommendation extensive searching showed no mention of prostate disease of any sort. Further searching indicated that the Canadian Urological Society report is pending.
Incidentally, I did not see any mention of the time involvement of the 'conversations' and of it's impact on the patient load of the physician and how this can best be accomplished.
No comments:
Post a Comment